Another study exploring melanoma found that while late-stage melanoma expresses IL-1β constitutively, intermediate-stage melanoma requires activation of the IL-1 receptor to secrete active IL-1β, and early-stage melanoma requires stimulation of the IL-1 receptor plus the co-stimulant muramyl dipeptide to secrete active IL-1β. Here, IL1B is linked to melanoma.